APA (7th ed.) Citation

P, R., J, Z., R, L., A, C., N, B., B, S., . . . H, K. (2022). Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research, 28(11), 2461. https://doi.org/10.1158/1078-0432.CCR-21-3207

Chicago Style (17th ed.) Citation

P, Rocha, et al. "Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 28, no. 11 (2022): 2461. https://doi.org/10.1158/1078-0432.CCR-21-3207.

MLA (9th ed.) Citation

P, Rocha, et al. "Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 28, no. 11, 2022, p. 2461, https://doi.org/10.1158/1078-0432.CCR-21-3207.